Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481010 · ClinicalTrials.gov registry record · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
A NA study of Hip Dysplasia, sponsored by Ottawa Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 7
- Study locations
NCT03481010: Recruiting NA study of Hip Dysplasia, sponsored by Ottawa Hospital Research Institute.
NCT03481010 is a NA study of Hip Dysplasia that is actively recruiting participants, run by Ottawa Hospital Research Institute. The registered enrollment target is 204 participants, above the 166-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (23% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03481010, a NA study of Hip Dysplasia, is actively recruiting participants, sponsored by Ottawa Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 7
- Study locations
Study Summary
At present, it is not clear whether performing a hip arthroscopy at the same time as a PAO improves patient outcomes after surgery compared to a PAO alone. This research project will randomize patients to receive either a PAO alone, or a PAO and a hip arthroscopy at the same time.
Primary Outcome
Patient-reported quality of life will be the primary outcome used for comparison between the two treatment groups as measured by the International Hip Outcome Tool (iHOT-33). The iHOT-33 is a validated, self-administered quality of life assessment tool for young, active patients with hip symptoms.
Conditions Studied
Interventions
- PROCEDURE PAO with hip arthroscopy
- PROCEDURE PAO without hip arthroscopy
Study Locations (7)
Ontario
- Children's Hospital of Eastern Ontario - Ottawa
- Ottawa Hospital Research Institute - Ottawa
Illinois
- Northwestern University - Chicago
Michigan
- William Beaumont Hospital - Royal Oak
Missouri
- The Washington University - St Louis
New York
- Hospital for Special Surgery - New York
Other
- CHU de Québec - Université Laval - Québec
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2030-12-31 |
| Phase | NA |
What NCT03481010 shows while recruiting
NCT03481010 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, above the 166-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (23% higher).
The record links to 1 condition, with Hip Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which PAO with hip arthroscopy is the first listed.
NCT03481010 lists 7 locations in 6 states (Ontario, Illinois, Michigan).
Frequently Asked Questions
What is clinical trial NCT03481010 about?
NCT03481010 is a clinical study titled "Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology". At present, it is not clear whether performing a hip arthroscopy at the same time as a PAO improves patient outcomes after surgery compared to a PAO alone. This research project will randomize patients to receive either a PAO alone, or a PAO and a hip arthroscopy at the same time.
What is the current status of trial NCT03481010?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2018-04-04. Estimated completion is 2030-12-31.
What conditions does trial NCT03481010 study?
This clinical trial studies the following conditions: Hip Dysplasia.
What interventions are being tested in trial NCT03481010?
The interventions under investigation include: PAO with hip arthroscopy (PROCEDURE), PAO without hip arthroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03481010?
This trial is sponsored by Ottawa Hospital Research Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03481010 being conducted?
This trial has 7 study locations across Illinois, Michigan, Missouri, New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Clinical Trial of Concomitant Hip Arthroscopy During PAO
RECRUITING · NA
-
Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy
RECRUITING · Phase 4
-
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
RECRUITING · Phase 2
-
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
- NCT05155163 · 204 participants · NA
Stepped Care for Patients to Optimize Whole Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI